Grail: Funding, Investors & Team (Sep 2026)
Grail develops a pan-cancer screening test designed to detect cancers at an early stage. Its pan-cancer screening test measures circulating nucleic acids in blood using high-intensity sequencing, population-scale clinical trials, enabling doctors to develop blood tests for early-stage cancer detection. The company was founded in 2016 by Alex Aravanis and Jeff Huber in Menlo Park, California.
Grail has raised $390M across 1 funding round on record, the most recent an undisclosed round of $390M announced in May 2020.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Grail Company Profile and Key Stats
Latest funding round on record: May 2020.
Grail Funding Rounds
Grail Founders and Leadership Team
Contact details for the Grail team: 1 of 1 has an email address on file.
Start 14-day free trial →Grail Funding Compared to Other Biotechnology Startups
Grail's latest round of $390M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Grail in Biotechnology and Menlo Park
Companies Similar to Grail
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Grail Funding FAQs
What does Grail do?
Grail develops a pan-cancer screening test designed to detect cancers at an early stage. Its pan-cancer screening test measures circulating nucleic acids in blood using high-intensity sequencing, population-scale clinical trials, enabling doctors to develop blood tests for early-stage cancer detection. The company was founded in 2016 by Alex Aravanis and Jeff Huber in Menlo Park, California.
How much funding has Grail raised?
Grail has raised $390M across 1 round on record. The most recent is an undisclosed round of $390M announced in May 2020.
When did Grail last raise funding?
Grail's most recent funding round on record is an undisclosed round of $390M, announced in May 2020.
Who is the CEO of Grail?
Jeff Huber is listed as CEO at Grail.
Where is Grail headquartered?
Grail is based in Menlo Park, California, United States.
How many employees does Grail have?
Grail is in the 501-1000 employee band.
How does Grail's funding compare to other Biotechnology startups?
Grail's latest round of $390M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Grail Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Grail is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.